137 related articles for article (PubMed ID: 33982234)
1. Low risk for all-cause mortality among patients with lung neuroendocrine tumors co-diagnosed with pituitary adenomas.
Peltz-Sinvani N; Percik R; Uri I; Kfir SK; Tirosh A; Tirosh A
Endocrine; 2021 Sep; 73(3):745-751. PubMed ID: 33982234
[TBL] [Abstract][Full Text] [Related]
2. Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution Experience.
Oliver DE; Laborde JM; Singh DP; Milano MT; Videtic GM; Williams GR; LaRiviere MJ; Chan JW; Peters GW; Decker RH; Samson P; Robinson CG; Breen WG; Owen D; Tian S; Higgins KA; Almeldin D; Jabbour SK; Wang F; Grass GD; Perez BA; Dilling TJ; Strosberg J; Rosenberg SA
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):849-857. PubMed ID: 36708788
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors.
Orozco-Morales M; Avilés-Salas A; Hernández-Pedro N; Catalán R; Cruz-Rico G; Colín-González AL; Dosal-Mancilla E; Barrios-Bernal P; Arrieta O
J Immunol Res; 2021; 2021():6632249. PubMed ID: 34195295
[TBL] [Abstract][Full Text] [Related]
4. Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines.
Singh S; Bergsland EK; Card CM; Hope TA; Kunz PL; Laidley DT; Lawrence B; Leyden S; Metz DC; Michael M; Modahl LE; Myrehaug S; Padda SK; Pommier RF; Ramirez RA; Soulen M; Strosberg J; Sung A; Thawer A; Wei B; Xu B; Segelov E
J Thorac Oncol; 2020 Oct; 15(10):1577-1598. PubMed ID: 32663527
[TBL] [Abstract][Full Text] [Related]
5. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
6. Vestibular schwannoma and pituitary adenoma in the same patient: coincidence or novel clinical association?
Carlson ML; Patel NS; Glasgow AE; Habermann EB; Grossardt BR; Link MJ
J Neurooncol; 2016 May; 128(1):101-108. PubMed ID: 26903014
[TBL] [Abstract][Full Text] [Related]
7. Serum NSE is Early Marker of Transformed Neuroendocrine Tumor After EGFR-TKI Treatment of Lung Adenocarcinoma.
Mao X; Liu J; Hu F; Niu Y; Pan F; Fu X; Jiang L
Cancer Manag Res; 2022; 14():1293-1302. PubMed ID: 35386183
[TBL] [Abstract][Full Text] [Related]
8. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
[TBL] [Abstract][Full Text] [Related]
10. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).
Fernandez A; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2010 Mar; 72(3):377-82. PubMed ID: 19650784
[TBL] [Abstract][Full Text] [Related]
12. Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome.
Möller-Goede DL; Brändle M; Landau K; Bernays RL; Schmid C
Eur J Endocrinol; 2011 Jan; 164(1):37-43. PubMed ID: 20926593
[TBL] [Abstract][Full Text] [Related]
13. Aggressive surgery for metastatic liver neuroendocrine tumors.
Norton JA; Warren RS; Kelly MG; Zuraek MB; Jensen RT
Surgery; 2003 Dec; 134(6):1057-63; discussion 1063-5. PubMed ID: 14668741
[TBL] [Abstract][Full Text] [Related]
14. CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report.
Del Gobbo A; Fusco N; Barella M; Ercoli G; Sciarra A; Palleschi A; Pagni F; Marchiò C; Papotti M; Ferrero S
Cell Oncol (Dordr); 2018 Dec; 41(6):687-691. PubMed ID: 30182340
[TBL] [Abstract][Full Text] [Related]
15. Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
Goncalves PH; Peterson SL; Vigneau FD; Shore RD; Quarshie WO; Islam K; Schwartz AG; Wozniak AJ; Gadgeel SM
Cancer; 2016 Jun; 122(12):1921-7. PubMed ID: 27062154
[TBL] [Abstract][Full Text] [Related]
16. Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic.
Marques NV; Kasuki L; Coelho MC; Lima CHA; Wildemberg LE; Gadelha MR
J Endocrinol Invest; 2017 Dec; 40(12):1381-1387. PubMed ID: 28689311
[TBL] [Abstract][Full Text] [Related]
17. Lower all-cause mortality rates in patients harboring pituitary carcinoma following the introduction of temozolomide.
Aharon-Hananel G; Percik R; Badarna M; Uri I; Tirosh A
Endocrine; 2019 Aug; 65(2):393-398. PubMed ID: 31267325
[TBL] [Abstract][Full Text] [Related]
18. Complexin-2 (CPLX2) as a potential prognostic biomarker in human lung high grade neuroendocrine tumors.
Komatsu H; Kakehashi A; Nishiyama N; Izumi N; Mizuguchi S; Yamano S; Inoue H; Hanada S; Chung K; Wei M; Suehiro S; Wanibuchi H
Cancer Biomark; 2013; 13(3):171-80. PubMed ID: 23912489
[TBL] [Abstract][Full Text] [Related]
19. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
[TBL] [Abstract][Full Text] [Related]
20. Lung neuroendocrine tumors: A systematic literature review (Review).
Savu C; Melinte A; Diaconu C; Stiru O; Gherghiceanu F; Tudorica ȘDO; Dumitrașcu OC; Bratu A; Balescu I; Bacalbasa N
Exp Ther Med; 2022 Feb; 23(2):176. PubMed ID: 35069857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
